|
Characteristics
|
Number of patients (%)
|
|---|
|
Age
| |
| ≧60 y.o. |
17(77.3)
|
|
<60 y.o.
|
5(22.7)
|
|
Gender
| |
|
Male
|
18(81.8)
|
|
Female
|
4(18.2)
|
|
ECOG
| |
|
0
|
3(13.6)
|
|
1
|
17(77.3)
|
|
2
|
2(9.1)
|
|
BCLC
| |
|
B
|
2(9.1)
|
|
C
|
20(90.9)
|
|
Vascular extension (PVTT & IVCTT)
| |
|
Yes
|
16(72.7)
|
|
No
|
6(27.3)
|
|
Child-Pugh stage
| |
|
A
|
20(90.9)
|
|
B
|
2(9.1)
|
|
Hepatitis virus
| |
|
B
|
12(54.5)
|
|
C
|
4(18.2)
|
|
Non B non C
|
6(27.3)
|
|
AFP
| |
|
<1500
|
15(68.2)
|
|
1500
|
7(31.8)
|
|
Tumor Location
| |
|
Right
|
21(95.5)
|
|
Left
|
1(4.5)
|
|
Tumor type
| |
|
Solitary
|
11(50)
|
|
Multiple
|
8(36.4)
|
|
Diffuse
|
3(13.6)
|
|
Tumor size
| |
|
10 cm
|
7(31.8)
|
|
>10 cm
|
15(68.2)
|
|
Radiation dose
| |
|
40 Gy
|
16(72.7)
|
|
< 40 Gy
|
6(27.3)
|
|
Pre-SBRT treatment
| |
|
Yes
|
9(40.9)
|
|
No
|
13(59.1)
|
|
Post – SBRT treatment
| |
|
Yes
|
6(27.3)
|
|
No
|
16(72.7)
|
